1. Home
  2. DARE vs GFAI Comparison

DARE vs GFAI Comparison

Compare DARE & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • GFAI
  • Stock Information
  • Founded
  • DARE 2015
  • GFAI 2018
  • Country
  • DARE United States
  • GFAI Singapore
  • Employees
  • DARE N/A
  • GFAI N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • DARE Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • DARE Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • DARE 28.0M
  • GFAI 23.5M
  • IPO Year
  • DARE N/A
  • GFAI N/A
  • Fundamental
  • Price
  • DARE $2.09
  • GFAI $1.10
  • Analyst Decision
  • DARE Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • DARE 2
  • GFAI 1
  • Target Price
  • DARE $10.00
  • GFAI $4.50
  • AVG Volume (30 Days)
  • DARE 182.2K
  • GFAI 540.1K
  • Earning Date
  • DARE 08-14-2025
  • GFAI 09-23-2025
  • Dividend Yield
  • DARE N/A
  • GFAI N/A
  • EPS Growth
  • DARE N/A
  • GFAI N/A
  • EPS
  • DARE N/A
  • GFAI N/A
  • Revenue
  • DARE N/A
  • GFAI $36,347,373.00
  • Revenue This Year
  • DARE $74,787.57
  • GFAI $5.66
  • Revenue Next Year
  • DARE $141.76
  • GFAI $4.69
  • P/E Ratio
  • DARE N/A
  • GFAI N/A
  • Revenue Growth
  • DARE N/A
  • GFAI 0.18
  • 52 Week Low
  • DARE $1.83
  • GFAI $0.76
  • 52 Week High
  • DARE $9.19
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • DARE 44.08
  • GFAI 45.26
  • Support Level
  • DARE $2.00
  • GFAI $1.04
  • Resistance Level
  • DARE $2.19
  • GFAI $1.11
  • Average True Range (ATR)
  • DARE 0.09
  • GFAI 0.08
  • MACD
  • DARE 0.03
  • GFAI -0.00
  • Stochastic Oscillator
  • DARE 34.78
  • GFAI 29.44

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: